Drug intelligence / Profile preview

sodium hyaluronate + triglycerides + phospholipids

Development stage
Unknown
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Ophthalmic, Topical
01

Overview

Sodium hyaluronate + triglycerides + phospholipids is a combination ophthalmic formulation used primarily as an artificial tear or ocular lubricant for the treatment of dry eye disease. Sodium hyaluronate, a salt form of hyaluronic acid, acts as a viscoelastic agent that retains water and stabilizes the tear film. Triglycerides and phospholipids are included to enhance the lipid layer of the tear film, improving its stability and reducing evaporation. This combination has been shown to increase tear film thickness (TFT) for longer periods compared to sodium hyaluronate alone, leading to improved subjective symptoms in patients with moderate-to-severe dry eye disease[4]. The mechanism involves physical stabilization and enhancement of both aqueous and lipid layers on the ocular surface.

Other names
HTP

Beyond the preview

Go deeper on sodium hyaluronate + triglycerides + phospholipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium hyaluronate + triglycerides + phospholipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call